The INVO Bioscience® mission is to increase access to care and expand fertility treatment and patient care across the globe. For many couples struggling with infertility, access to treatment is often not possible. Financial challenges, limited availability of specialized medical care, religious, social or cultural roadblocks can prevent these hopeful parents from realizing their dream to have a baby.
INVOcell® is the first Intravaginal Culture (IVC) system granted FDA clearance in the United States, providing millions of infertile couples across the country access to this revolutionary infertility treatment. This novel device utilizes the women’s vagina as an incubator to support a more natural fertilization and embryo development environment. The INVOcell device and INVO® Procedure will provide couples the opportunity to have an additional option other than the thirty-year-old traditional treatments, Intrauterine Insemination (IUI) and In Vitro Fertilization (IVF).